News

Find News

Filter articles

Showing 3041 to 3050 of 3112 results

Glenmark confirms Vimpat challenge

US16-07-2013

Pharmaceutical company Glenmark Generics has confirmed that it has filed ANDAs with the US FDA to market generic versions of epilepsy drug Vimpat.

IPAB rejects Monsanto plant patent

India15-07-2013

India’s Intellectual Property Appellate Board has affirmed that US agricultural company Monsanto cannot obtain a patent covering transgenic plants, two years after it was first rejected.

Australian bid for OxyContin generic dismissed

Australia12-07-2013Legal developments

The Federal Court of Australia has dismissed Spirit Pharmaceutical’s bid to introduce a generic version of painkiller OxyContin.

Greenberg Traurig names new IP co-chair in Boston

US11-07-2013

US law firm Greenberg Traurig has appointed shareholder Jennifer Camacho as co-chair of its Boston IP group.

Myriad sues Ambry over cancer gene screening tests

US10-07-2013

Biotech company Myriad Genetics has filed a patent infringement case against Ambry Genetic Corp for allegedly infringing 10 patents related to genetic diagnostic testing.

FDA stings thousands of fake drug sites

US09-07-2013

The US Food and Drug Administration (FDA) last month seized and shut down 1,677 illegal pharmacy websites selling $41,104,386 worth of fake medicines.

Novartis strikes vaccine licensing deal with Indian biopharma

India08-07-2013

Novartis has signed a development and licensing agreement with Indian biopharmaceutical company Biological E Limited (BioE) to deliver two vaccines that protect against typhoid and paratyphoid fevers.

EU court overrules commission in Orphacol drug case

EU05-07-2013

The General Court of the European Union has annulled the European Commission’s decision to refuse marketing authorisation for orphan drug Orphacol.

UCB challenges Teva generic drug application

US03-07-2013

Belgian pharmaceutical company UCB SA has sued drug-maker Teva Pharmaceutical Industries to stop it manufacturing a generic version of epilepsy drug Vimpat.

AbbVie triumphs in Humira case

US02-07-2013Legal developments

Pharmaceutical company AbbVie has won a patent case against UK research body The Kennedy Institute of Rheumatology Trust relating to the arthritis medication Humira.

Showing 3041 to 3050 of 3112 results

LSIPR